Time series analysis of antibacterial usage and bacterial resistance in China: observations from a tertiary hospital from 2014 to 2018

References

• O’Neill J[Website on the Internet]. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations; 2016 Available from: http://amr-review.org/Publications.html.  Accessed April 24, 2019.
   Google Scholar
• Roope LSJ, Smith RD, Pouwels KB, et al. The challenge of antimicrobial resistance: what economics can contribute. Science. 2019;364:6435. doi:10.1126/science.aav6390
   Web of Science ®Google Scholar
• Lishman H, Costelloe C, Hopkins S, et al. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study. Int J Antimicrob Agents. 2018;52(6):790–798. doi:10.1016/j.ijantimicag.2018.08.01330145249
   PubMed Web of Science ®Google Scholar
• Gajdacs M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics. 2019;8:2. doi:10.3390/antibiotics8020052
   Web of Science ®Google Scholar
• Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49(8):1175–1184. doi:10.1086/60563019739972
   PubMed Web of Science ®Google Scholar
• Gajdacs M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24:5. doi:10.3390/molecules24050892
   Web of Science ®Google Scholar
• Zhang QQ, Ying GG, Pan CG, Liu YS, Zhao JL. Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ Sci Technol. 2015;49(11):6772–6782. doi:10.1021/acs.est.5b0072925961663
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control (ECDC) [Website on the Internet]. Europe. Directory of Online Resources for the Prevention and Control of Antimicrobial Resistance (AMR) and Healthcare-associated Infections (HAI); 2014. Available from: http://www.ecdc.europa.eu/en/healthtopics/Healthcare-associated_infections/guidance-infection-prevention-control/Pages/guidance-prevention-control-infections-caused-by-multidrug-resistant-bacteria-and-healthcare-associated-infections.aspx.  Accessed April 24, 2019.
   Google Scholar
• Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol. 2016;22(Suppl 1):S9–S14. doi:10.1016/j.cmi.2016.01.001
   Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–S134. doi:10.1093/cid/ciy65730423045
   PubMed Web of Science ®Google Scholar
• National Health Commission [Website on the Internet]. China. National Action Plan for Containing Bacterial Resistance; 2016 Available from: http://www.nhc.gov.cn/xxgk/pages/viewdocument.jsp?dispatchDate=&staticUrl=/yzygj/s3593/201608/f1ed26a0c8774e1c8fc89dd481ec84d7.shtml.  Accessed April 24, 2019.
   Google Scholar
• Centers for Disease Control and Prevention, US Department of Health and Human Services [Website on the Internet]. US. Antibiotic Resistance Threats in the United States; 2013 Available from: http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.  Accessed April 24, 2019.
   Google Scholar
• Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(10014):168–175. doi:10.1016/S0140-6736(15)00474-226603918
   PubMed Web of Science ®Google Scholar
• Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Rev Microbiol. 2010;8(4):260–271. doi:10.1038/nrmicro231920208551
   PubMed Web of Science ®Google Scholar
• Callens B, Cargnel M, Sarrazin S, et al. Associations between a decreased veterinary antimicrobial use and resistance in commensal Escherichia coli from Belgian livestock species (2011–2015). Prev Vet Med. 2018;157:50–58. doi:10.1016/j.prevetmed.2017.10.01330086849
   PubMed Web of Science ®Google Scholar
• Asencio Egea MA, Huertas Vaquero M, Carranza Gonzalez R, Herraez Carrera O, Redondo Gonzalez O, Arias Arias A. Trend and seasonality of community-acquired Escherichia coli antimicrobial resistance and its dynamic relationship with antimicrobial use assessed by ARIMA models. Enferm Infecc Microbiol Clin. 2018;36(8):502–506. doi:10.1016/j.eimc.2017.10.01329217096
   PubMed Web of Science ®Google Scholar
• Thaulow CM, Berild D, Eriksen BH, Myklebust TA, Blix HS. Potential for more rational use of antibiotics in hospitalized children in a country with low resistance: data from eight point prevalence surveys. Pediatr Infect Dis J. 2019;38(4):384–389. doi:10.1097/INF.000000000000210630882728
   PubMed Web of Science ®Google Scholar
• Cui D, Liu X, Hawkey P, et al. Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance. J Int Med Res. 2017;45(6):1768–1778. doi:10.1177/030006051668623029239248
   PubMed Web of Science ®Google Scholar
• Kim B, Kim Y, Hwang H, et al. Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: a nationwide multicenter study. Medicine. 2018;97(51):e13719. doi:10.1097/MD.000000000001371930572507
   PubMed Web of Science ®Google Scholar
• Zou YM, Ma Y, Liu JH, et al. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009–2013). Eur J Clin Microbiol Infect Dis. 2015;34(4):795–803. doi:10.1007/s10096-014-2293-625487131
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre For Drug Statistic Methodology [homepage on the Internet]. Norway. Anatomical Therapeutic Chemical Code; 2013 Available from: (www.whocc.no. Accessed April 24, 2019.
   Google Scholar
• Chen J, Min R, Wang H, Zhao S, Li H, Fang P. Trends and drivers of inpatient antibiotic consumption among 89 China Tertiary General Hospitals from 2011Q1 to 2015Q4. Biomed Res Int. 2018;2018:5968653. doi:10.1155/2018/596865330519582
   PubMed Web of Science ®Google Scholar
• Tang Q, Song P, Li J, Kong F, Sun L, Xu L. Control of antibiotic resistance in China must not be delayed: the current state of resistance and policy suggestions for the government, medical facilities, and patients. Biosci Trends. 2016;10(1):1–6. doi:10.5582/bst.2016.0103426961210
   PubMed Web of Science ®Google Scholar
• Meng X, Liu S, Duan J, et al. Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital. BMC Infect Dis. 2017;17(1):82. doi:10.1186/s12879-017-2757-228095785
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang Y, Wan Q. Pseudomonas aeruginosa bacteremia among liver transplant recipients. Infect Drug Resist. 2018;11:2345–2356. doi:10.2147/IDR.S18028330532566
   PubMed Web of Science ®Google Scholar
• Zhang D, Hu S, Sun J, et al. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017. J Infect Public Health. 2019;12(2):195–199. doi:10.1016/j.jiph.2018.10.00330385238
   PubMed Web of Science ®Google Scholar
• Bao L, Peng R, Wang Y, et al. Significant reduction of antibiotic consumption and patients’ costs after an action plan in China, 2010–2014. PLoS One. 2015;10(3):e0118868. doi:10.1371/journal.pone.011886825767891
   PubMed Web of Science ®Google Scholar
• National Health Commission [Website on the Internet]. China. Notice on Further Carrying Out Antimicrobials Special Rectification Activity on Clinical Rational Use; 2013 Available from: http://www.nhc.gov.cn/yzygj/s3585u/201305/823b9d131ff4416ab7b41b2c4e1f0e83.shtml. Accessed April 24, 2019.
   Google Scholar
• Yusuf E, Versporten A, Goossens H. Is there any difference in quality of prescribing between antibacterials and antifungals? Results from the first global point prevalence study (Global PPS) of antimicrobial consumption and resistance from 53 countries. J Antimicrob Chemother. 2017;72(10):2906–2909. doi:10.1093/jac/dkx23629091210
   PubMed Web of Science ®Google Scholar
• Piperaki ET, Tzouvelekis LS, Miriagou V, Daikos GL. Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol. 2019. doi:10.1016/j.cmi.2019.03.014
   Web of Science ®Google Scholar
• Huang ZY, Li J, Shui J, Wang HC, Hu YM, Zou MX. Co-existence of blaOXA-23 and blaVIM in carbapenem-resistant Acinetobacter baumannii isolates belonging to global complex 2 in a chinese teaching hospital. Chin Med J. 2019. doi:10.1097/CM9.0000000000000193
   Web of Science ®Google Scholar
• Nie XM, Huang PH, Ye QF, Wan QQ. The distribution, drug resistance, and clinical characteristics of Acinetobacter baumannii infections in solid organ transplant recipients. Transplant Proc. 2015;47(10):2860–2864. doi:10.1016/j.transproceed.2015.09.03726707303
   PubMed Web of Science ®Google Scholar
• Du X, Xu X, Yao J, et al. Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis. Am J Infect Control. 2019. doi:10.1016/j.ajic.2019.03.003
   Web of Science ®Google Scholar
• Chen F, Wang L, Wang M, et al. Genetic characterization and in vitro activity of antimicrobial combinations of multidrug-resistant Acinetobacter baumannii from a general hospital in China. Oncol Lett. 2018;15(2):2305–2315. doi:10.3892/ol.2017.760029434938
   PubMed Web of Science ®Google Scholar
• Abdallah M, Badawi M, Alzaagi I, Issa KN, Rasheed A, Alharthy A. Effect of short-term carbapenem restriction on the incidence of non-pseudomonal multi-drug resistant Gram-negative bacilli in an intensive care unit. J Chemother. 2019;1–6. doi:10.1080/1120009X.2019.1601802
   Web of Science ®Google Scholar
• Munoz-Price LS, Rosa R, Castro JG, et al. Evaluating the impact of antibiotic exposures as time-dependent variables on the acquisition of carbapenem-resistant Acinetobacter baumannii. Crit Care Med. 2016;44(10):e949–e956. doi:10.1097/CCM.000000000000184827167999
   PubMed Web of Science ®Google Scholar
• Wickman PA, Black JA, Smith Moland E, Thomson KS, Hanson ND. In vitro development of resistance to DX-619 and other quinolones in enterococci. J Antimicrob Chemother. 2006;58(6):1268–1273. doi:10.1093/jac/dkl42117062613
   PubMed Web of Science ®Google Scholar
• Gao W, Howden BP, Stinear TP. Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen. Curr Opin Microbiol. 2018;41:76–82. doi:10.1016/j.mib.2017.11.03029227922
   PubMed Web of Science ®Google Scholar
• Nordmann P, Naas T, Fortineau N, Poirel L. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol. 2007;10(5):436–440. doi:10.1016/j.mib.2007.07.00417765004
   PubMed Web of Science ®Google Scholar
• Guo Y, Tomich AD, McElheny CL, et al. High-level fosfomycin resistance in vancomycin-resistant Enterococcus faecium. Emerg Infect Dis. 2017;23(11):1902–1904. doi:10.3201/eid2311.17113029048285
   PubMed Web of Science ®Google Scholar
• Lopez-Lozano JM, Lawes T, Nebot C, et al. A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance. Nature Microbiol. 2019;4(7):1160–1172. doi:10.1038/s41564-019-0410-0
   Web of Science ®Google Scholar
• Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin Microbiol Rev. 2017;30(1):1–22. doi:10.1128/CMR.00042-1627795305
   PubMed Web of Science ®Google Scholar